{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:28:39Z","timestamp":1789050519681,"version":"build-2803163510"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11064-024-04177-x","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T05:01:35Z","timestamp":1717218095000},"page":"1926-1944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects"],"prefix":"10.1007","volume":"49","author":[{"given":"Md.","family":"Faysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerrouki","family":"Dehbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrukh","family":"Zehravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk Hussein","family":"Sweilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Akiful","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusuma Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita D.","family":"Chakole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish P.","family":"Shelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Sirikonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"Nafady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharuk L.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firzan","family":"Nainu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha Bin","family":"Emran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"4177_CR1","doi-asserted-by":"crossref","unstructured":"Wang Y, Li H, He Q, Zou R, Cai J, Zhang L (2023) Ferroptosis: Underlying mechanisms and involvement in neurodegenerative diseases. Apoptosis:1\u201319","DOI":"10.1007\/s10495-023-01902-9"},{"key":"4177_CR2","doi-asserted-by":"publisher","first-page":"a041046","DOI":"10.1101\/cshperspect.a041046","volume":"14","author":"DR Green","year":"2022","unstructured":"Green DR (2022) The mitochondrial pathway of apoptosis part II: the BCL-2 protein family. Cold Spring Harb Perspect Biol 14:a041046","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4177_CR3","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.3390\/ijms24043380","volume":"24","author":"PS Tsoi","year":"2023","unstructured":"Tsoi PS, Quan MD, Ferreon JC, Ferreon ACM (2023) Aggregation of disordered proteins associated with neurodegeneration. Int J Mol Sci 24:3380","journal-title":"Int J Mol Sci"},{"key":"4177_CR4","doi-asserted-by":"publisher","first-page":"1105247","DOI":"10.3389\/fncel.2023.1105247","volume":"17","author":"MS Karvandi","year":"2023","unstructured":"Karvandi MS, Sheikhzadeh Hesari F, Aref AR, Mahdavi M (2023) The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: the role of ER stress, oxidative stress, and neuroinflammation. Front Cell Neurosci 17:1105247","journal-title":"Front Cell Neurosci"},{"key":"4177_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/antiox10091353","volume":"10","author":"FR Buccellato","year":"2021","unstructured":"Buccellato FR, D\u2019Anca M, Fenoglio C, Scarpini E, Galimberti D (2021) Role of oxidative damage in alzheimer\u2019s disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery. Antioxidants 10:1353","journal-title":"Antioxidants"},{"key":"4177_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines9020099","volume":"9","author":"S Devi","year":"2021","unstructured":"Devi S, Kumar V, Singh SK, Dubey AK, Kim J-J (2021) Flavonoids: potential candidates for the treatment of neurodegenerative disorders. Biomedicines 9:99","journal-title":"Biomedicines"},{"key":"4177_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejmech.2017.09.001","volume":"153","author":"C Spagnuolo","year":"2018","unstructured":"Spagnuolo C, Moccia S, Russo GL (2018) Anti-inflammatory effects of flavonoids in neurodegenerative disorders. Eur J Med Chem 153:105\u2013115","journal-title":"Eur J Med Chem"},{"key":"4177_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12640-016-9600-1","volume":"30","author":"SL Costa","year":"2016","unstructured":"Costa SL, Silva VDA, dos Santos Souza C, Santos CC, Paris I, Mu\u00f1oz P, Segura-Aguilar J (2016) Impact of plant-derived flavonoids on neurodegenerative diseases. Neurotox Res 30:41\u201352","journal-title":"Neurotox Res"},{"key":"4177_CR9","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3390\/molecules28041845","volume":"28","author":"W Sun","year":"2023","unstructured":"Sun W, Shahrajabian MH (2023) Therapeutic potential of phenolic compounds in medicinal plants\u2014natural health products for human health. Molecules 28:1845","journal-title":"Molecules"},{"key":"4177_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2174\/1389557519666190617150051","volume":"20","author":"Z Calis","year":"2020","unstructured":"Calis Z, Mogulkoc R, Baltaci AK (2020) The roles of flavonols\/flavonoids in neurodegeneration and neuroinflammation. Mini Rev Med Chem 20:1475\u20131488","journal-title":"Mini Rev Med Chem"},{"key":"4177_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.tips.2012.08.002","volume":"33","author":"QR Jones","year":"2012","unstructured":"Jones QR, Warford J, Rupasinghe HV, Robertson GS (2012) Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 33:602\u2013610","journal-title":"Trends Pharmacol Sci"},{"key":"4177_CR12","doi-asserted-by":"publisher","first-page":"111817","DOI":"10.1016\/j.fct.2020.111817","volume":"146","author":"H Khan","year":"2020","unstructured":"Khan H, Tundis R, Ullah H, Aschner M, Belwal T, Mirzaei H, Akkol EK (2020) Flavonoids targeting NRF2 in neurodegenerative disorders. Food Chem Toxicol 146:111817","journal-title":"Food Chem Toxicol"},{"key":"4177_CR13","doi-asserted-by":"publisher","first-page":"e1000088","DOI":"10.1371\/journal.pcbi.1000088","volume":"4","author":"S Nadkarni","year":"2008","unstructured":"Nadkarni S, Jung P, Levine H (2008) Astrocytes optimize the synaptic transmission of information. PLoS Comput Biol 4:e1000088","journal-title":"PLoS Comput Biol"},{"key":"4177_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2008.03.039","volume":"158","author":"M Santello","year":"2009","unstructured":"Santello M, Volterra A (2009) Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience 158:253\u2013259","journal-title":"Neuroscience"},{"key":"4177_CR15","doi-asserted-by":"publisher","first-page":"573256","DOI":"10.3389\/fimmu.2020.573256","volume":"11","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer M, Rothhammer V (2020) Protective functions of reactive astrocytes following central nervous system insult. Front Immunol 11:573256","journal-title":"Front Immunol"},{"key":"4177_CR16","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/jnr.24922","volume":"99","author":"CG Hart","year":"2021","unstructured":"Hart CG, Karimi-Abdolrezaee S (2021) Recent insights on astrocyte mechanisms in CNS homeostasis, pathology, and repair. J Neurosci Res 99:2427\u20132462","journal-title":"J Neurosci Res"},{"key":"4177_CR17","doi-asserted-by":"publisher","first-page":"792764","DOI":"10.3389\/fncel.2021.792764","volume":"15","author":"G Yu","year":"2021","unstructured":"Yu G, Zhang Y, Ning B (2021) Reactive astrocytes in central nervous system injury: subgroup and potential therapy. Front Cell Neurosci 15:792764","journal-title":"Front Cell Neurosci"},{"key":"4177_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Reviews Neurol 6:193\u2013201","journal-title":"Nat Reviews Neurol"},{"key":"4177_CR19","doi-asserted-by":"crossref","unstructured":"Rani N, Alam MM, Jamal A, Ghaffar OB, Parvez S (2023) Caenorhabditis elegans: a transgenic model for studying age-associated neurodegenerative diseases. Ageing Res Rev :102036","DOI":"10.1016\/j.arr.2023.102036"},{"key":"4177_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines9050524","volume":"9","author":"IG Onyango","year":"2021","unstructured":"Onyango IG, Jauregui GV, \u010carn\u00e1 M, Bennett JP Jr, Stokin GB (2021) Neuroinflammation in Alzheimer\u2019s disease. Biomedicines 9:524","journal-title":"Biomedicines"},{"key":"4177_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/antiox9080740","volume":"9","author":"P Michalska","year":"2020","unstructured":"Michalska P, Le\u00f3n R (2020) When it comes to an end: oxidative stress crosstalk with protein aggregation and neuroinflammation induce neurodegeneration. Antioxidants 9:740","journal-title":"Antioxidants"},{"key":"4177_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"4177_CR23","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","volume":"31","author":"N Exner","year":"2012","unstructured":"Exner N, Lutz AK, Haass C, Winklhofer KF (2012) Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences. EMBO J 31:3038\u20133062","journal-title":"EMBO J"},{"key":"4177_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s12640-021-00356-8","volume":"39","author":"M El-Gamal","year":"2021","unstructured":"El-Gamal M, Salama M, Collins-Praino LE, Baetu I, Fathalla AM, Soliman AM, Mohamed W, Moustafa AA (2021) Neurotoxin-induced rodent models of Parkinson\u2019s disease: benefits and drawbacks. Neurotox Res 39:897\u2013923","journal-title":"Neurotox Res"},{"key":"4177_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biomedicines10020371","volume":"10","author":"NA Gouda","year":"2022","unstructured":"Gouda NA, Elkamhawy A, Cho J (2022) Emerging therapeutic strategies for Parkinson\u2019s disease and future prospects: a 2021 update. Biomedicines 10:371","journal-title":"Biomedicines"},{"key":"4177_CR26","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","volume":"23","author":"DM Teleanu","year":"2022","unstructured":"Teleanu DM, Niculescu A-G, Lungu II, Radu CI, Vlad\u00e2cenco O, Roza E, Cost\u0103chescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23:5938","journal-title":"Int J Mol Sci"},{"key":"4177_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/antiox12030673","volume":"12","author":"J Segura-Aguilar","year":"2023","unstructured":"Segura-Aguilar J, Mannervik B (2023) A preclinical model for parkinson\u2019s disease based on transcriptional gene activation via KEAP1\/NRF2 to develop new antioxidant therapies. Antioxidants 12:673","journal-title":"Antioxidants"},{"key":"4177_CR28","doi-asserted-by":"publisher","first-page":"106528","DOI":"10.1016\/j.biocel.2024.106528","volume":"168","author":"A Chagraoui","year":"2024","unstructured":"Chagraoui A, Anouar Y, De Deurwaerdere P, Arias HR (2024) To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson\u2019s disease. Int J Biochem Cell Biol 168:106528","journal-title":"Int J Biochem Cell Biol"},{"key":"4177_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/npp.2011.212","volume":"37","author":"Y Smith","year":"2012","unstructured":"Smith Y, Wichmann T, Factor SA, DeLong MR (2012) Parkinson\u2019s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 37:213\u2013246","journal-title":"Neuropsychopharmacology"},{"key":"4177_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S1474-4422(09)70225-X","volume":"8","author":"A Antonini","year":"2009","unstructured":"Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH (2009) A reassessment of risks and benefits of dopamine agonists in Parkinson\u2019s disease. Lancet Neurol 8:929\u2013937","journal-title":"Lancet Neurol"},{"key":"4177_CR31","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/biomedicines11102793","volume":"11","author":"F De Marchi","year":"2023","unstructured":"De Marchi F, Munitic I, Vidatic L, Papi\u0107 E, Ra\u010dki V, Nimac J, Jurak I, Novotni G, Rogelj B, Vuletic V (2023) Overlapping neuroimmune mechanisms and therapeutic targets in neurodegenerative disorders. Biomedicines 11:2793","journal-title":"Biomedicines"},{"key":"4177_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s13311-020-00905-7","volume":"17","author":"CR Donnelly","year":"2020","unstructured":"Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, Ji R-R (2020) Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics 17:846\u2013860","journal-title":"Neurotherapeutics"},{"key":"4177_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jphs.2020.07.004","volume":"144","author":"O Fatoba","year":"2020","unstructured":"Fatoba O, Itokazu T, Yamashita T (2020) Microglia as therapeutic target in central nervous system disorders. J Pharmacol Sci 144:102\u2013118","journal-title":"J Pharmacol Sci"},{"key":"4177_CR34","doi-asserted-by":"crossref","unstructured":"Peterson LJ, Flood PM (2012) Oxidative stress and microglial cells in Parkinson\u2019s disease. Mediators of inflammation 2012","DOI":"10.1155\/2012\/401264"},{"key":"4177_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.foodchem.2008.05.111","volume":"112","author":"H Li","year":"2009","unstructured":"Li H, Wang X, Li Y, Li P, Wang H (2009) Polyphenolic compounds and antioxidant properties of selected China wines. Food Chem 112:454\u2013460","journal-title":"Food Chem"},{"key":"4177_CR36","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutritional Sci 5:e47","journal-title":"J Nutritional Sci"},{"key":"4177_CR37","doi-asserted-by":"publisher","first-page":"243S","DOI":"10.1093\/ajcn\/81.1.243S","volume":"81","author":"G Williamson","year":"2005","unstructured":"Williamson G, Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81:243S\u2013255S","journal-title":"Am J Clin Nutr"},{"key":"4177_CR38","first-page":"724","volume":"71","author":"H Vrbovsk\u00e1","year":"2016","unstructured":"Vrbovsk\u00e1 H, Babincov\u00e1 M (2016) Comparative analysis of synthetic and nutraceutical antioxidants as possible neuroprotective agents. Die Pharmazie-An Int J Pharm Sci 71:724\u2013726","journal-title":"Die Pharmazie-An Int J Pharm Sci"},{"key":"4177_CR39","doi-asserted-by":"crossref","unstructured":"Kesharwani V, Kabra S, Semwal BC, Saini D (2024) Neuroprotective effects of flavonoids. Advances in flavonoids for Human Health and Prevention of Diseases. Apple Academic, pp 95\u2013123","DOI":"10.1201\/9781003369813-5"},{"key":"4177_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/1028415X.2022.2028058","volume":"26","author":"M Ramezani","year":"2023","unstructured":"Ramezani M, Meymand AZ, Khodagholi F, Kamsorkh HM, Asadi E, Noori M, Rahimian K, Shahrbabaki AS, Talebi A, Parsaiyan H (2023) A role for flavonoids in the prevention and\/or treatment of cognitive dysfunction, learning, and memory deficits: a review of preclinical and clinical studies. Nutr Neurosci 26:156\u2013172","journal-title":"Nutr Neurosci"},{"key":"4177_CR41","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","volume":"28","author":"RA Arias-S\u00e1nchez","year":"2023","unstructured":"Arias-S\u00e1nchez RA, Torner L, Fenton Navarro B (2023) Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection. Molecules 28:5415","journal-title":"Molecules"},{"key":"4177_CR42","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.1021\/jf049243r","volume":"52","author":"HJ Heo","year":"2004","unstructured":"Heo HJ, Lee CY (2004) Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem 52:7514\u20137517","journal-title":"J Agric Food Chem"},{"key":"4177_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"H Khan","year":"2019","unstructured":"Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK (2019) Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules 10:59","journal-title":"Biomolecules"},{"key":"4177_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2015.01.027","volume":"93","author":"AM Sabogal-Gu\u00e1queta","year":"2015","unstructured":"Sabogal-Gu\u00e1queta AM, Munoz-Manco JI, Ram\u00edrez-Pineda JR, Lamprea-Rodriguez M, Osorio E, Cardona-G\u00f3mez GP (2015) The flavonoid quercetin ameliorates Alzheimer\u2019s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer\u2019s disease model mice. Neuropharmacology 93:134\u2013145","journal-title":"Neuropharmacology"},{"key":"4177_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.11.061","volume":"517","author":"E Puerta","year":"2017","unstructured":"Puerta E, Su\u00e1rez-Santiago JE, Santos-Magalh\u00e3es NS, Ramirez MJ, Irache JM (2017) Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int J Pharm 517:50\u201357","journal-title":"Int J Pharm"},{"key":"4177_CR46","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.phymed.2016.07.007","volume":"23","author":"S Mart\u00edn-Arag\u00f3n","year":"2016","unstructured":"Mart\u00edn-Arag\u00f3n S, Jim\u00e9nez-Aliaga KL, Bened\u00ed J, Bermejo-Besc\u00f3s P (2016) Neurohormetic responses of quercetin and rutin in a cell line over-expressing the amyloid precursor protein (APPswe cells). Phytomedicine 23:1285\u20131294","journal-title":"Phytomedicine"},{"key":"4177_CR47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/10715760500233113","volume":"39","author":"V Zbarsky","year":"2005","unstructured":"Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson\u2019s disease. Free Radic Res 39:1119\u20131125","journal-title":"Free Radic Res"},{"key":"4177_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2131\/jts.38.25","volume":"38","author":"N Haleagrahara","year":"2013","unstructured":"Haleagrahara N, Siew CJ, Ponnusamy K (2013) Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. J Toxicol Sci 38:25\u201333","journal-title":"J Toxicol Sci"},{"key":"4177_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","volume":"236","author":"S Karuppagounder","year":"2013","unstructured":"Karuppagounder S, Madathil S, Pandey M, Haobam R, Rajamma U, Mohanakumar K (2013) Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson\u2019s disease in rats. Neuroscience 236:136\u2013148","journal-title":"Neuroscience"},{"key":"4177_CR50","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/S1353-8020(09)70811-9","volume":"15","author":"MI Ekstrand","year":"2009","unstructured":"Ekstrand MI, Galter D (2009) The MitoPark Mouse\u2013An animal model of Parkinson\u2019s disease with impaired respiratory chain function in dopamine neurons. Parkinsonism Relat Disord 15:S185\u2013S188","journal-title":"Parkinsonism Relat Disord"},{"key":"4177_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2016.04.008","volume":"108","author":"Y Du","year":"2016","unstructured":"Du Y, Qu J, Zhang W, Bai M, Zhou Q, Zhang Z, Li Z, Miao J (2016) Morin reverses neuropathological and cognitive impairments in APPswe\/PS1dE9 mice by targeting multiple pathogenic mechanisms. Neuropharmacology 108:1\u201313","journal-title":"Neuropharmacology"},{"key":"4177_CR52","doi-asserted-by":"publisher","first-page":"174506","DOI":"10.1016\/j.ejphar.2021.174506","volume":"910","author":"N Mohammadi","year":"2021","unstructured":"Mohammadi N, Asle-Rousta M, Rahnema M, Amini R (2021) Morin attenuates memory deficits in a rat model of Alzheimer\u2019s disease by ameliorating oxidative stress and neuroinflammation. Eur J Pharmacol 910:174506","journal-title":"Eur J Pharmacol"},{"key":"4177_CR53","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jnr.23764","volume":"94","author":"KM Lee","year":"2016","unstructured":"Lee KM, Lee Y, Chun HJ, Kim AH, Kim JY, Lee JY, Ishigami A, Lee J (2016) Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson\u2019s disease. J Neurosci Res 94:865\u2013878","journal-title":"J Neurosci Res"},{"key":"4177_CR54","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s12035-016-9795-4","volume":"54","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO (2017) Neuroprotective effect of fisetin against amyloid-beta-induced cognitive\/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol Neurobiol 54:2269\u20132285","journal-title":"Mol Neurobiol"},{"key":"4177_CR55","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/jcm8060850","volume":"8","author":"A Ahmad","year":"2019","unstructured":"Ahmad A, Ali T, Rehman SU, Kim MO (2019) Phytomedicine-based potent antioxidant, fisetin protects CNS-insult LPS-induced oxidative stress-mediated neurodegeneration and memory impairment. J Clin Med 8:850","journal-title":"J Clin Med"},{"key":"4177_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/19390211.2019.1710646","volume":"18","author":"K Alikatte","year":"2021","unstructured":"Alikatte K, Palle S, Rajendra Kumar J, Pathakala N (2021) Fisetin improved rotenone-induced behavioral deficits, oxidative changes, and mitochondrial dysfunctions in rat model of Parkinson\u2019s disease. J Diet Supplements 18:57\u201371","journal-title":"J Diet Supplements"},{"key":"4177_CR57","doi-asserted-by":"publisher","first-page":"115215","DOI":"10.1016\/j.biopha.2023.115215","volume":"165","author":"S Jin","year":"2023","unstructured":"Jin S, Zhang L, Wang L (2023) Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: from chemistry to medicine. Biomed Pharmacother 165:115215","journal-title":"Biomed Pharmacother"},{"key":"4177_CR58","unstructured":"Bahrani H (2013) Isolation and characterization of acetylcholinestrase inhibitors from Aquilaria species for treatment of Alzhimer Disease (AD). University of Malaya"},{"key":"4177_CR59","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/cercor\/bhv227","volume":"26","author":"SH Dennis","year":"2016","unstructured":"Dennis SH, Pasqui F, Colvin EM, Sanger H, Mogg AJ, Felder CC, Broad LM, Fitzjohn SM, Isaac JT, Mellor JR (2016) Activation of muscarinic M1 acetylcholine receptors induces long-term potentiation in the hippocampus. Cereb Cortex 26:414\u2013426","journal-title":"Cereb Cortex"},{"key":"4177_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1046\/j.1471-4159.1995.64041888.x","volume":"64","author":"DD Flynn","year":"1995","unstructured":"Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AI (1995) Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer\u2019s disease. J Neurochem 64:1888\u20131891","journal-title":"J Neurochem"},{"key":"4177_CR61","doi-asserted-by":"publisher","first-page":"13793","DOI":"10.1038\/s41598-020-70236-2","volume":"10","author":"F Rahul, Naz","year":"2020","unstructured":"Rahul, Naz F, Jyoti S, Siddique YH (2020) Effect of kaempferol on the transgenic Drosophila model of Parkinson\u2019s disease. Sci Rep 10:13793","journal-title":"Sci Rep"},{"key":"4177_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.phrs.2017.10.008","volume":"128","author":"SF Nabavi","year":"2018","unstructured":"Nabavi SF, Khan H, D\u2019onofrio G, \u0160amec D, Shirooie S, Dehpour AR, Arg\u00fcelles S, Habtemariam S, Sobarzo-Sanchez E (2018) Apigenin as neuroprotective agent: of mice and men. Pharmacol Res 128:359\u2013365","journal-title":"Pharmacol Res"},{"key":"4177_CR63","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0278-6915(03)00146-7","volume":"41","author":"AT Smolinski","year":"2003","unstructured":"Smolinski AT, Pestka JJ (2003) Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb1 (ginseng) and parthenolide (feverfew). Food Chem Toxicol 41:1381\u20131390","journal-title":"Food Chem Toxicol"},{"key":"4177_CR64","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.imr.2017.04.003","volume":"6","author":"YH Siddique","year":"2017","unstructured":"Siddique YH, Jyoti S (2017) Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson\u2019s disease exposed to apigenin. Integr Med Res 6:245\u2013253","journal-title":"Integr Med Res"},{"key":"4177_CR65","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuint.2015.09.006","volume":"90","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Braidy N, Habtemariam S, Orhan IE, Daglia M, Manayi A, Gortzi O, Nabavi SM (2015) Neuroprotective effects of chrysin: from chemistry to medicine. Neurochem Int 90:224\u2013231","journal-title":"Neurochem Int"},{"key":"4177_CR66","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.2174\/1568026616666160204121725","volume":"16","author":"S Fazel Nabavi","year":"2016","unstructured":"Fazel Nabavi S, Braidy N, Habtemariam S, Sureda A, Manayi A, Mohammad Nabavi S (2016) Neuroprotective effects of fisetin in Alzheimer\u2019s and Parkinson\u2019s diseases: from chemistry to medicine. Curr Top Med Chem 16:1910\u20131915","journal-title":"Curr Top Med Chem"},{"key":"4177_CR67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.exger.2017.05.014","volume":"95","author":"Y Kwon","year":"2017","unstructured":"Kwon Y (2017) Luteolin as a potential preventive and therapeutic candidate for Alzheimer\u2019s disease. Exp Gerontol 95:39\u201343","journal-title":"Exp Gerontol"},{"key":"4177_CR68","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.3390\/molecules18078083","volume":"18","author":"W Wu","year":"2013","unstructured":"Wu W, Li D, Zong Y, Zhu H, Pan D, Xu T, Wang T, Wang T (2013) Luteolin inhibits inflammatory responses via p38\/MK2\/TTP-mediated mRNA stability. Molecules 18:8083\u20138094","journal-title":"Molecules"},{"key":"4177_CR69","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3892\/mmr.2016.5052","volume":"13","author":"H Wang","year":"2016","unstructured":"Wang H, Wang H, Cheng H, Che Z (2016) Ameliorating effect of luteolin on memory impairment in an Alzheimer\u2019s disease model. Mol Med Rep 13:4215\u20134220","journal-title":"Mol Med Rep"},{"key":"4177_CR70","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/biof.1706","volume":"47","author":"YH Siddique","year":"2021","unstructured":"Siddique YH (2021) Role of luteolin in overcoming Parkinson\u2019s disease. BioFactors 47:198\u2013206","journal-title":"BioFactors"},{"key":"4177_CR71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/1028415X.2018.1500124","volume":"23","author":"AR Khalatbary","year":"2020","unstructured":"Khalatbary AR, Khademi E (2020) The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection. Nutr Neurosci 23:281\u2013294","journal-title":"Nutr Neurosci"},{"key":"4177_CR72","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harbor Perspect Med 2:a009399","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"4177_CR73","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang Y, Mucke L (2012) Alzheimer mechanisms and therapeutic strategies. Cell 148:1204\u20131222","journal-title":"Cell"},{"key":"4177_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31024\/ajpp.2019.5.s1.1","volume":"5","author":"R Prasad","year":"2019","unstructured":"Prasad R, Prasad SB (2019) A review on the chemistry and biological properties of Rutin, a promising nutraceutical agent. Asian J Pharm Pharmacol 5:1\u201320","journal-title":"Asian J Pharm Pharmacol"},{"key":"4177_CR75","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.neuroscience.2012.02.046","volume":"210","author":"H Javed","year":"2012","unstructured":"Javed H, Khan M, Ahmad A, Vaibhav K, Ahmad M, Khan A, Ashafaq M, Islam F, Siddiqui M, Safhi M (2012) Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 210:340\u2013352","journal-title":"Neuroscience"},{"key":"4177_CR76","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3892\/ijmm.2013.1375","volume":"32","author":"KB Magalingam","year":"2013","unstructured":"Magalingam KB, Radhakrishnan A, Haleagrahara N (2013) Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int J Mol Med 32:235\u2013240","journal-title":"Int J Mol Med"},{"key":"4177_CR77","unstructured":"Suganya SN, Thangarajan Sumathi TS (2015) Rutin attenuates 3-nitropropionic acid induced behavioural alterations and mitochondrial dysfunction in the striatum of rat brain"},{"key":"4177_CR78","doi-asserted-by":"crossref","unstructured":"Man M-Q, Yang B, Elias PM (2019) Benefits of hesperidin for cutaneous functions. Evidence-Based Complementary and Alternative Medicine 2019","DOI":"10.1155\/2019\/2676307"},{"key":"4177_CR79","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11064-015-1525-1","volume":"40","author":"AJ Thenmozhi","year":"2015","unstructured":"Thenmozhi AJ, Raja TRW, Janakiraman U, Manivasagam T (2015) Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer\u2019s disease in Wistar rats. Neurochem Res 40:767\u2013776","journal-title":"Neurochem Res"},{"key":"4177_CR80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneuroim.2016.11.009","volume":"302","author":"D Haghmorad","year":"2017","unstructured":"Haghmorad D, Mahmoudi MB, Salehipour Z, Jalayer Z, Rastin M, Kokhaei P, Mahmoudi M (2017) Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis. J Neuroimmunol 302:23\u201333","journal-title":"J Neuroimmunol"},{"key":"4177_CR81","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuro.2012.07.007","volume":"33","author":"ET Menze","year":"2012","unstructured":"Menze ET, Tadros MG, Abdel-Tawab AM, Khalifa AE (2012) Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 33:1265\u20131275","journal-title":"Neurotoxicology"},{"key":"4177_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-020-03033-z","volume":"20","author":"Y Taheri","year":"2020","unstructured":"Taheri Y, Suleria HAR, Martins N, Sytar O, Beyatli A, Yeskaliyeva B, Seitimova G, Salehi B, Semwal P, Painuli S (2020) Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications. BMC Complement Med Ther 20:1\u201314","journal-title":"BMC Complement Med Ther"},{"key":"4177_CR83","first-page":"1934578X1501001","volume":"10","author":"ME Clementi","year":"2015","unstructured":"Clementi ME, Tringali G, Triggiani D, Giardina B (2015) Aloe arborescens extract protects IMR-32 cells against alzheimer amyloid beta peptide via inhibition of radical peroxide production. Nat Prod Commun 10:1934578X1501001147","journal-title":"Nat Prod Commun"},{"key":"4177_CR84","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s11064-020-03062-7","volume":"45","author":"D Liu","year":"2020","unstructured":"Liu D, Du D (2020) Mulberry fruit extract alleviates cognitive impairment by promoting the clearance of amyloid-\u03b2 and inhibiting neuroinflammation in Alzheimer\u2019s disease mice. Neurochem Res 45:2009\u20132019","journal-title":"Neurochem Res"},{"key":"4177_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1574885513666180529114546","volume":"14","author":"G Ara","year":"2019","unstructured":"Ara G, Afzal M, Jyoti S, Naz F, Siddique YH (2019) Effect of Myricetin on the loss of dopaminergic neurons in the transgenic Drosophila model of Parkinson\u2019s disease. Curr Drug Therapy 14:58\u201364","journal-title":"Curr Drug Therapy"},{"key":"4177_CR86","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1039\/C6FO00419A","volume":"7","author":"S Wu","year":"2016","unstructured":"Wu S, Yue Y, Peng A, Zhang L, Xiang J, Cao X, Ding H, Yin S (2016) Myricetin ameliorates brain injury and neurological deficits via Nrf2 activation after experimental stroke in middle-aged rats. Food Funct 7:2624\u20132634","journal-title":"Food Funct"},{"key":"4177_CR87","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3390\/ijms18091989","volume":"18","author":"E Bahar","year":"2017","unstructured":"Bahar E, Kim J-Y, Yoon H (2017) Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS\/NF-\u03baB and HO-1\/Nrf2 pathways. Int J Mol Sci 18:1989","journal-title":"Int J Mol Sci"},{"key":"4177_CR88","first-page":"5169","volume":"8","author":"X Liu","year":"2016","unstructured":"Liu X, Yu Z, Huang X, Gao Y, Wang X, Gu J, Xue S (2016) Peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-\u03baB pathway. Am J Translational Res 8:5169","journal-title":"Am J Translational Res"},{"key":"4177_CR89","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3233\/JPD-012110","volume":"2","author":"MY Patel","year":"2012","unstructured":"Patel MY, Panchal HV, Ghribi O, Benzeroual KE (2012) The neuroprotective effect of fisetin in the MPTP model of Parkinson\u2019s disease. J Parkinson\u2019s Disease 2:287\u2013302","journal-title":"J Parkinson\u2019s Disease"},{"key":"4177_CR90","doi-asserted-by":"publisher","first-page":"104140","DOI":"10.1016\/j.jff.2020.104140","volume":"74","author":"X Pan","year":"2020","unstructured":"Pan X, Liu X, Zhao H, Wu B, Liu G (2020) Antioxidant, anti-inflammatory and neuroprotective effect of kaempferol on rotenone-induced Parkinson\u2019s disease model of rats and SH-S5Y5 cells by preventing loss of tyrosine hydroxylase. J Funct Foods 74:104140","journal-title":"J Funct Foods"},{"key":"4177_CR91","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cns.12648","volume":"23","author":"B Bertolino","year":"2017","unstructured":"Bertolino B, Crupi R, Impellizzeri D, Bruschetta G, Cordaro M, Siracusa R, Esposito E, Cuzzocrea S (2017) Beneficial effects of co-ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism. CNS Neurosci Ther 23:87\u201398","journal-title":"CNS Neurosci Ther"},{"key":"4177_CR92","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jnutbio.2006.11.001","volume":"18","author":"S-J Kim","year":"2007","unstructured":"Kim S-J, Jeong H-J, Lee K-M, Myung N-Y, An N-H, Yang WM, Park SK, Lee H-J, Hong S-H, Kim H-M (2007) Epigallocatechin-3-gallate suppresses NF-\u03baB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J Nutr Biochem 18:587\u2013596","journal-title":"J Nutr Biochem"},{"key":"4177_CR93","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3945\/jn.109.109785","volume":"139","author":"JW Lee","year":"2009","unstructured":"Lee JW, Lee YK, Ban JO, Ha TY, Yun YP, Han SB, Oh KW, Hong JT (2009) Green tea (-)-epigallocatechin-3-gallate inhibits \u03b2-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-\u03baB pathways in mice. J Nutr 139:1987\u20131993","journal-title":"J Nutr"},{"key":"4177_CR94","doi-asserted-by":"publisher","first-page":"e25456","DOI":"10.1371\/journal.pone.0025456","volume":"6","author":"K Herges","year":"2011","unstructured":"Herges K, Millward JM, Hentschel N, Infante-Duarte C, Aktas O, Zipp F (2011) Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation. PLoS ONE 6:e25456","journal-title":"PLoS ONE"},{"key":"4177_CR95","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijdevneu.2018.06.009","volume":"69","author":"R Khalaj","year":"2018","unstructured":"Khalaj R, Moghaddam AH, Zare M (2018) Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism. Int J Dev Neurosci 69:80\u201387","journal-title":"Int J Dev Neurosci"},{"key":"4177_CR96","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1021\/jf035079g","volume":"52","author":"HJ Heo","year":"2004","unstructured":"Heo HJ, Kim D-O, Shin SC, Kim MJ, Kim BG, Shin D-H (2004) Effect of antioxidant flavanone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 52:1520\u20131525","journal-title":"J Agric Food Chem"},{"key":"4177_CR97","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nut.2013.06.006","volume":"30","author":"X Zhou","year":"2014","unstructured":"Zhou X, Yuan L, Zhao X, Hou C, Ma W, Yu H, Xiao R (2014) Genistein antagonizes inflammatory damage induced by \u03b2-amyloid peptide in microglia through TLR4 and NF-\u03baB. Nutrition 30:90\u201395","journal-title":"Nutrition"},{"key":"4177_CR98","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/jmf.2014.3150","volume":"18","author":"W Ma","year":"2015","unstructured":"Ma W, Ding B, Yu H, Yuan L, Xi Y, Xiao R (2015) Genistein alleviates \u03b2-amyloid-induced inflammatory damage through regulating toll-like receptor 4\/nuclear factor \u03ba B. J Med Food 18:273\u2013279","journal-title":"J Med Food"},{"key":"4177_CR99","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.arcmed.2013.12.008","volume":"45","author":"X Zhao","year":"2014","unstructured":"Zhao X, Yuan L, Yu H, Xi Y, Ma W, Zhou X, Ding J, Xiao R (2014) Genistein inhibited amyloid-\u03b2 induced inflammatory damage in C6 glial cells. Arch Med Res 45:152\u2013157","journal-title":"Arch Med Res"},{"key":"4177_CR100","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10753-014-0102-0","volume":"38","author":"AB Aras","year":"2015","unstructured":"Aras AB, Guven M, Akman T, Alacam H, Kalkan Y, Silan C, Cosar M (2015) Genistein exerts neuroprotective effect on focal cerebral ischemia injury in rats. Inflammation 38:1311\u20131321","journal-title":"Inflammation"},{"key":"4177_CR101","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s11064-012-0786-1","volume":"37","author":"M Ashafaq","year":"2012","unstructured":"Ashafaq M, Raza SS, Khan MM, Ahmad A, Javed H, Ahmad ME, Tabassum R, Islam F, Siddiqui MS, Safhi MM (2012) Catechin hydrate ameliorates redox imbalance and limits inflammatory response in focal cerebral ischemia. Neurochem Res 37:1747\u20131760","journal-title":"Neurochem Res"},{"key":"4177_CR102","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1021\/acs.jafc.6b01707","volume":"64","author":"B Guo","year":"2016","unstructured":"Guo B, Zheng C, Cai W, Cheng J, Wang H, Li H, Sun Y, Cui W, Wang Y, Han Y (2016) Multifunction of chrysin in Parkinson\u2019s model: anti-neuronal apoptosis, neuroprotection via activation of MEF2D, and inhibition of monoamine oxidase-B. J Agric Food Chem 64:5324\u20135333","journal-title":"J Agric Food Chem"},{"key":"4177_CR103","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neuroscience.2013.11.051","volume":"259","author":"Y Yabuki","year":"2014","unstructured":"Yabuki Y, Ohizumi Y, Yokosuka A, Mimaki Y, Fukunaga K (2014) Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. Neuroscience 259:126\u2013141","journal-title":"Neuroscience"},{"key":"4177_CR104","doi-asserted-by":"publisher","first-page":"e0146197","DOI":"10.1371\/journal.pone.0146197","volume":"11","author":"W Wang","year":"2016","unstructured":"Wang W, Ma X, Han J, Zhou M, Ren H, Pan Q, Zheng C, Zheng Q (2016) Neuroprotective effect of scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor. PLoS ONE 11:e0146197","journal-title":"PLoS ONE"},{"key":"4177_CR105","doi-asserted-by":"publisher","first-page":"104997","DOI":"10.1016\/j.phrs.2020.104997","volume":"159","author":"MMA de Almeida","year":"2020","unstructured":"de Almeida MMA, Pieropan F, de Mattos Oliveira L, dos Santos Junior MC, David JM, David JP, da Silva VDA, dos Santos Souza C, Costa SL, Butt AM (2020) The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination. Pharmacol Res 159:104997","journal-title":"Pharmacol Res"},{"key":"4177_CR106","doi-asserted-by":"crossref","unstructured":"Atoki AV, Aja PM, Shinkafi TS, Ondari EN, Awuchi CG (2023) Naringenin: its chemistry and roles in neuroprotection. Nutr Neurosci :1\u201330","DOI":"10.1080\/1028415X.2023.2243089"},{"key":"4177_CR107","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tiv.2013.12.002","volume":"28","author":"Y Yang","year":"2014","unstructured":"Yang Y, Bai L, Li X, Xiong J, Xu P, Guo C, Xue M (2014) Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood\u2013brain barrier cell and Caco-2 cell models. Toxicol in Vitro 28:388\u2013396","journal-title":"Toxicol in Vitro"},{"key":"4177_CR108","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s43450-023-00452-0","volume":"34","author":"NK Singh","year":"2024","unstructured":"Singh NK, Verma N, Gupta JK, Raghav J (2024) Anti-amnesic and neuroprotective potential of Genistein against Alzheimer\u2019s Disease. Revista Brasileira De Farmacognosia 34:80\u201392","journal-title":"Revista Brasileira De Farmacognosia"},{"key":"4177_CR109","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1570163815666180219115453","volume":"16","author":"T Farkhondeh","year":"2019","unstructured":"Farkhondeh T, Yazdi HS, Samarghandian S (2019) The protective effects of green tea catechins in the management of neurodegenerative diseases: a review. Curr Drug Discov Technol 16:57\u201365","journal-title":"Curr Drug Discov Technol"},{"key":"4177_CR110","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/07315724.2021.1981487","volume":"42","author":"G \u00d6zduran","year":"2023","unstructured":"\u00d6zduran G, Becer E, Vatansever HS (2023) The role and mechanisms of action of catechins in neurodegenerative diseases. J Am Nutr Association 42:67\u201374","journal-title":"J Am Nutr Association"},{"key":"4177_CR111","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/01616412.2021.2024715","volume":"44","author":"G \u00d6zduran","year":"2022","unstructured":"\u00d6zduran G, Becer E, Vatansever HS, Y\u00fccecan S (2022) Neuroprotective effects of catechins in an experimental Parkinson\u2019s disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects. Neurol Res 44:511\u2013523","journal-title":"Neurol Res"},{"key":"4177_CR112","doi-asserted-by":"publisher","first-page":"104612","DOI":"10.1016\/j.neuint.2019.104612","volume":"132","author":"E Angelopoulou","year":"2020","unstructured":"Angelopoulou E, Pyrgelis E-S, Piperi C (2020) Neuroprotective potential of chrysin in Parkinson\u2019s disease: molecular mechanisms and clinical implications. Neurochem Int 132:104612","journal-title":"Neurochem Int"},{"key":"4177_CR113","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.npep.2016.03.002","volume":"58","author":"A Vedagiri","year":"2016","unstructured":"Vedagiri A, Thangarajan S (2016) Mitigating effect of chrysin loaded solid lipid nanoparticles against amyloid \u03b225\u201335 induced oxidative stress in rat hippocampal region: an efficient formulation approach for Alzheimer\u2019s disease. Neuropeptides 58:111\u2013125","journal-title":"Neuropeptides"},{"key":"4177_CR114","doi-asserted-by":"publisher","first-page":"112874","DOI":"10.1016\/j.jpba.2019.112874","volume":"177","author":"Y Qi","year":"2020","unstructured":"Qi Y, Cheng X, Jing H, Yan T, Xiao F, Wu B, Bi K, Jia Y (2020) Comparative pharmacokinetic study of the components in Alpinia Oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. Herb pair and its single herb between normal and Alzheimer\u2019s disease rats by UPLC-MS\/MS. J Pharm Biomed Anal 177:112874","journal-title":"J Pharm Biomed Anal"},{"key":"4177_CR115","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/ijms18071424","volume":"18","author":"BK Lee","year":"2017","unstructured":"Lee BK, Lee WJ, Jung Y-S (2017) Chrysin attenuates VCAM-1 expression and monocyte adhesion in lipopolysaccharide-stimulated brain endothelial cells by preventing NF-\u03baB signaling. Int J Mol Sci 18:1424","journal-title":"Int J Mol Sci"},{"key":"4177_CR116","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jff.2013.12.011","volume":"6","author":"S Li","year":"2014","unstructured":"Li S, Wang H, Guo L, Zhao H, Ho C-T (2014) Chemistry and bioactivity of nobiletin and its metabolites. J Funct Foods 6:2\u201310","journal-title":"J Funct Foods"},{"key":"4177_CR117","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1447-0594.2012.00892.x","volume":"13","author":"T Seki","year":"2013","unstructured":"Seki T, Kamiya T, Furukawa K, Azumi M, Ishizuka S, Takayama S, Nagase S, Arai H, Yamakuni T, Yaegashi N (2013) Nobiletin-rich Citrus reticulata peels, a kampo medicine for Alzheimer\u2019s disease: a case series. Geriatr Gerontol Int 13:236\u2013238","journal-title":"Geriatr Gerontol Int"},{"key":"4177_CR118","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog Neurobiol 64:575\u2013611","journal-title":"Prog Neurobiol"},{"key":"4177_CR119","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00394-015-1016-9","volume":"55","author":"MH Alharbi","year":"2016","unstructured":"Alharbi MH, Lamport DJ, Dodd GF, Saunders C, Harkness L, Butler LT, Spencer JP (2016) Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males. Eur J Nutr 55:2021\u20132029","journal-title":"Eur J Nutr"},{"key":"4177_CR120","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1177\/0269881109106923","volume":"24","author":"AB Scholey","year":"2010","unstructured":"Scholey AB, French SJ, Morris PJ, Kennedy DO, Milne AL, Haskell CF (2010) Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol 24:1505\u20131514","journal-title":"J Psychopharmacol"},{"key":"4177_CR121","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clinthera.2013.04.006","volume":"35","author":"A Taliou","year":"2013","unstructured":"Taliou A, Zintzaras E, Lykouras L, Francis K (2013) An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin Ther 35:592\u2013602","journal-title":"Clin Ther"},{"key":"4177_CR122","doi-asserted-by":"crossref","unstructured":"Gonzales MM, Garbarino V, Zilli EM, Petersen R, Kirkland J, Tchkonia T, Musi N, Seshadri S, Craft S, Orr ME (2022) Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): a pilot clinical trial. The journal of prevention of Alzheimer\u2019s disease:1\u20138","DOI":"10.14283\/jpad.2021.62"},{"key":"4177_CR123","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13195-022-01097-2","volume":"14","author":"J Vi\u00f1a","year":"2022","unstructured":"Vi\u00f1a J, Escudero J, Baquero M, Cebri\u00e1n M, Carbonell-As\u00edns JA, Mu\u00f1oz JE, Satorres E, Mel\u00e9ndez JC, Ferrer-Rebolleda J, C\u00f3zar-Santiago MdP (2022) Genistein effect on cognition in prodromal Alzheimer\u2019s disease patients. The GENIAL clinical trial. Alzheimers Res Ther 14:164","journal-title":"Alzheimers Res Ther"},{"key":"4177_CR124","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000017242","volume":"11","author":"PL Le Bars","year":"2000","unstructured":"Le Bars PL, Kieser M, Itil KZ (2000) A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761\u00ae in dementia. Dement Geriatr Cogn Disord 11:230\u2013237","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4177_CR125","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/nu13020434","volume":"13","author":"YX You","year":"2021","unstructured":"You YX, Shahar S, Rajab NF, Haron H, Yahya HM, Mohamad M, Din NC, Maskat MY (2021) Effects of 12 weeks Cosmos caudatus supplement among older adults with mild cognitive impairment: a randomized, double-blind and placebo-controlled trial. Nutrients 13:434","journal-title":"Nutrients"},{"key":"4177_CR126","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2003-45117","volume":"36","author":"S Kanowski","year":"2003","unstructured":"Kanowski S, Hoerr R (2003) Ginkgo biloba extract EGb 761\u00ae in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 36:297\u2013303","journal-title":"Pharmacopsychiatry"},{"key":"4177_CR127","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0091-3057(03)00116-3","volume":"75","author":"R Duffy","year":"2003","unstructured":"Duffy R, Wiseman H, File SE (2003) Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 75:721\u2013729","journal-title":"Pharmacol Biochem Behav"},{"key":"4177_CR128","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3945\/ajcn.114.088518","volume":"101","author":"RJ Kean","year":"2015","unstructured":"Kean RJ, Lamport DJ, Dodd GF, Freeman JE, Williams CM, Ellis JA, Butler LT, Spencer JP (2015) Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: an 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. Am J Clin Nutr 101:506\u2013514","journal-title":"Am J Clin Nutr"},{"key":"4177_CR129","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.3390\/nu6104032","volume":"6","author":"K Ide","year":"2014","unstructured":"Ide K, Yamada H, Takuma N, Park M, Wakamiya N, Nakase J, Ukawa Y, Sagesaka YM (2014) Green tea consumption affects cognitive dysfunction in the elderly: a pilot study. Nutrients 6:4032\u20134042","journal-title":"Nutrients"},{"key":"4177_CR130","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/nn.3850","volume":"17","author":"AM Brickman","year":"2014","unstructured":"Brickman AM, Khan UA, Provenzano FA, Yeung L-K, Suzuki W, Schroeter H, Wall M, Sloan RP, Small SA (2014) Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat Neurosci 17:1798\u20131803","journal-title":"Nat Neurosci"},{"key":"4177_CR131","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1017\/S0007114509990201","volume":"102","author":"AA Thorp","year":"2009","unstructured":"Thorp AA, Sinn N, Buckley JD, Coates AM, Howe PR (2009) Soya isoflavone supplementation enhances spatial working memory in men. Br J Nutr 102:1348\u20131354","journal-title":"Br J Nutr"},{"key":"4177_CR132","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/gme.0b013e31802c4f4f","volume":"14","author":"SC Ho","year":"2007","unstructured":"Ho SC, Chan AS, Ho YP, So EK, Sham A, Zee B, Woo JL (2007) Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 14:489\u2013499","journal-title":"Menopause"},{"key":"4177_CR133","doi-asserted-by":"crossref","unstructured":"Wightman EL, Haskell CF, Forster JS, Veasey RC, Kennedy DO (2012) Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo\u2010controlled, crossover investigation. Human Psychopharmacology: Clinical and Experimental 27:177\u2013186","DOI":"10.1002\/hup.1263"},{"key":"4177_CR134","doi-asserted-by":"publisher","first-page":"107797","DOI":"10.1016\/j.soilbio.2020.107797","volume":"145","author":"MJ Zwetsloot","year":"2020","unstructured":"Zwetsloot MJ, Ucros JM, Wickings K, Wilhelm RC, Sparks J, Buckley DH, Bauerle TL (2020) Prevalent root-derived phenolics drive shifts in microbial community composition and prime decomposition in forest soil. Soil Biol Biochem 145:107797","journal-title":"Soil Biol Biochem"},{"key":"4177_CR135","doi-asserted-by":"crossref","unstructured":"Kakkar S, Bais S (2014) A review on protocatechuic acid and its pharmacological potential. International Scholarly Research Notices 2014","DOI":"10.1155\/2014\/952943"},{"key":"4177_CR136","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jnutbio.2016.12.014","volume":"42","author":"M Hytti","year":"2017","unstructured":"Hytti M, Szab\u00f3 D, Piippo N, Korhonen E, Honkakoski P, Kaarniranta K, Petrovski G, Kauppinen A (2017) Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells. J Nutr Biochem 42:37\u201342","journal-title":"J Nutr Biochem"},{"key":"4177_CR137","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.fct.2018.10.040","volume":"123","author":"Y Liu","year":"2019","unstructured":"Liu Y, Qiu S, Wang L, Zhang N, Shi Y, Zhou H, Liu X, Shao L, Liu X, Chen J (2019) Reproductive and developmental toxicity study of caffeic acid in mice. Food Chem Toxicol 123:106\u2013112","journal-title":"Food Chem Toxicol"},{"key":"4177_CR138","doi-asserted-by":"publisher","first-page":"657665","DOI":"10.3389\/fonc.2021.657665","volume":"11","author":"S-M Wang","year":"2021","unstructured":"Wang S-M, Yang P-W, Feng X-J, Zhu Y-W, Qiu F-J, Hu X-D, Zhang S-H (2021) Apigenin inhibits the growth of hepatocellular carcinoma cells by affecting the expression of microRNA transcriptome. Front Oncol 11:657665","journal-title":"Front Oncol"},{"key":"4177_CR139","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/nu11102308","volume":"11","author":"A Lee","year":"2019","unstructured":"Lee A, Beaubernard L, Lamothe V, Bennetau-Pelissero C (2019) New evaluation of isoflavone exposure in the French population. Nutrients 11:2308","journal-title":"Nutrients"},{"key":"4177_CR140","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.addr.2015.10.021","volume":"98","author":"C He","year":"2016","unstructured":"He C, Tang Z, Tian H, Chen X (2016) Co-delivery of chemotherapeutics and proteins for synergistic therapy. Adv Drug Deliv Rev 98:64\u201376","journal-title":"Adv Drug Deliv Rev"},{"key":"4177_CR141","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s40265-022-01717-z","volume":"82","author":"SU Rawal","year":"2022","unstructured":"Rawal SU, Patel BM, Patel MM (2022) New drug delivery systems developed for brain targeting. Drugs 82:749\u2013792","journal-title":"Drugs"},{"key":"4177_CR142","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","volume":"6","author":"MT Manzari","year":"2021","unstructured":"Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA (2021) Targeted drug delivery strategies for precision medicines. Nat Reviews Mater 6:351\u2013370","journal-title":"Nat Reviews Mater"},{"key":"4177_CR143","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.3748\/wjg.v18.i30.3923","volume":"18","author":"D-X Cao","year":"2012","unstructured":"Cao D-X, Li Z-J, Jiang X-O, Lum YL, Khin E, Lee NP, Wu G-H, Luk JM (2012) Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterology: WJG 18:3923","journal-title":"World J Gastroenterology: WJG"},{"key":"4177_CR144","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/19440049.2015.1084653","volume":"32","author":"RR Maronpot","year":"2015","unstructured":"Maronpot RR, Koyanagi M, Davis J, Recio L, Marbury D, Boyle M, Hayashi S-m (2015) Safety assessment and single-dose toxicokinetics of the flavouring agent myricitrin in Sprague\u2013Dawley rats. Food Addit Contaminants: Part A 32:1799\u20131809","journal-title":"Food Addit Contaminants: Part A"},{"key":"4177_CR145","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.toxrep.2014.07.014","volume":"1","author":"R Chen","year":"2014","unstructured":"Chen R, Lin J, Hong J, Han D, Zhang AD, Lan R, Fu L, Wu Z, Lin J, Zhang W (2014) Potential toxicity of quercetin: the repression of mitochondrial copy number via decreased POLG expression and excessive TFAM expression in irradiated murine bone marrow. Toxicol Rep 1:450\u2013458","journal-title":"Toxicol Rep"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04177-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04177-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04177-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:09:15Z","timestamp":1720584555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04177-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":145,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["4177"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04177-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}}]}}